Riskpilot← Back to searchSign inGet full accessBARDUFOSS APOTEK AS
ASActiveOrg 925413542Øvreveien 2, 9325 BardufossRetail sale of pharmaceutical products · NACE 4773Est. 20204 employees
Revenue 2025
NOK 0
EBITDA margin
—
-100% vs 2024
Equity ratio
69.5%
Financial strength
Net profit 2025
NOK -8K
-100% vs 2024
| Revenue | NOK 0 | — |
| EBITDA | NOK -11K | -100% |
| Net profit | NOK -8K | -100% |
| Total assets | NOK 3,8M | +0% |
| Equity | NOK 2,6M | +0% |
| Employees | 4 | — |
Legal name
BARDUFOSS APOTEK AS
Org number
925413542
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
3. august 2020
Share capital
NOK 400 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-01-31
Financial year
January – December
Signatory rights
Styrets leder alene eller to styremedlemmer i fellesskap.
Company purpose
Eierskap og drift av apotek, handel med apotekvarer og andre relaterte produkter, aktuelle konsulent og rådgivningstjenester.
Address
Øvreveien 2, 9325 Bardufoss
Phone
+4777838339
Email
apotek1.bardufoss@apotek1.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 993 | 9 253 | 12 947 | 7 646 | 0 |
| Staff expenses | −2 106 | −2 909 | −2 867 | −772 | −0 |
| EBITDA | −989 | −706 | 75 | 3 893 | −11 |
| Depreciation & amort. | −119 | −250 | −250 | −62 | −0 |
| EBIT | −1 108 | −956 | −175 | 3 831 | −11 |
| Net financials | −1 | −27 | −22 | 1 | 0 |
| Profit before tax | −1 109 | −983 | −197 | 3 832 | −11 |
| Tax | −244 | −217 | −43 | −105 | −2 |
| Net profit | −865 | −766 | −153 | 3 937 | −8 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 145 | 3 690 | 3 669 | 3 769 | 3 770 |
| Equity | −568 | −1 153 | −1 307 | 2 630 | 2 622 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 713 | 4 843 | 4 976 | 1 139 | 1 148 |
| Total debt | 3 713 | 4 843 | 4 976 | 1 139 | 1 148 |
EBITDA margin
-1068500.0%
This company
15.8%
Market median
-6762758% vs market
20212025
Equity ratio
69.5%
This company
38.2%
Market median
+82% vs market
20212025
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20212025
Net profit margin
-833400.0%
This company
8.1%
Market median
-10288989% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-01-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
TD Chief Executive Officer | Chief Executive Officer | 2021 – 2023 |
CJ Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2020 – 2024 | |
| Board of Directors | 2020 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 | |
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Marvik Invest As
BARDUFOSS APOTEK AS Board members of BARDUFOSS APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tijana Dimitrijevic | Chief Executive Officer | 0 companies |
| Christoffer Jacobsen Løkse | Chief Executive Officer | 0 companies |
| John Giæver | Chairman | 0 companies |
| Børge Moholt | Chairman | 0 companies |
| Øystein Askim | Board of Directors | 0 companies |
| Johan Giæver Marvik | Board of Directors | 0 companies |